Kevin Ferro serves as Executive at KOS PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Kevin Ferro has executed 19 insider transactions totaling $864.1K, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 30, 2023 involved selling 27,242 shares valued at $0.
Kevin Ferro currently holds 27,242 shares of KOS PHARMACEUTICALS INC (KOSP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kevin Ferro has been a net buyer of KOSP stock. They have purchased $864.1K and sold $0 worth of shares.
Kevin Ferro's most recent insider trade was on Nov 30, 2023, when they sold 27,242 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Apr 3, 2023 | GHL | $0 | Award | 3,523 | $N/A | Discretionary |
| Jan 4, 2023 | GHL | $0 | Award | 3,049 | $N/A | Discretionary |
| Oct 4, 2022 | GHL | $0 | Award | 5,261 | $N/A | Discretionary |
| Jul 5, 2022 | GHL | $0 | Award | 3,389 | $N/A | Discretionary |
| May 2, 2022 | GHL | $121.5K | Purchase | 10,000 | $12.15 | Discretionary |
| Apr 5, 2022 | GHL | $0 | Award | 2,020 | $N/A | Discretionary |
| Jan 4, 2022 | GHL | $0 | Award | 1,743 | $N/A | Discretionary |
| Oct 5, 2021 | GHL | $0 | Award | 2,137 | $N/A | Discretionary |
| Jul 2, 2021 | GHL | $0 | Award | 2,008 | $N/A | Discretionary |
| May 11, 2021 | GHL | $323.0K | Purchase | 20,312 | $15.90 | Discretionary |
| May 11, 2021 | GHL | $248.6K | Purchase | 15,625 | $15.91 | Discretionary |
| May 7, 2021 | GHL | $102.1K | Purchase | 6,420 | $15.90 | Discretionary |
| Apr 6, 2021 | GHL | $0 | Award | 1,264 | $N/A | Discretionary |
| Mar 9, 2021 | GHL | $61.5K | Purchase | 4,244 | $14.50 | Discretionary |
| Mar 5, 2021 | GHL | $7.4K | Purchase | 500 | $14.85 | Discretionary |
| Dec 13, 2006 | KOSP | $411.1K | Tender | 5,270 | $78.00 | Discretionary |
| Apr 27, 2006 | KOSP | $0 | Award | 5,000 | $N/A | Discretionary |